2016 Print Media Planner
News
1
#
*
Most Efficient Newspaper
Rank Publication
• Oncologists and Hematologist/Oncologists • Total Scripts Written • Formulary Committee Members • Early Adopters of New Drugs • Physicians Under 45 Years Old
Cost (Gross)
Exposures
CPM Exposures
% Universe Exposures
Index Exposures
1
Journal 1
$4,780.00
1,793
2,665.55
15.35
0.89
2
Journal 2
$6,225.00
1,863
3,341.54
15.94
0.82
3
Clinical Oncology News
$2,575.00
1,189
2,165.76
10.17
0.82
4
Journal 4
$6,420.00
1,731
3,709.60
14.81
0.76
5
Journal 5
$4,700.00
1,500
3,132.44
12.84
0.75
For more information, or to reserve advertising space, please contact: Julianna Dawson
[email protected] (212) 957-5300 x271
Michael Enright
[email protected] (212) 957-5300 x272
* Kantar Media June 2015 Medical Surgical Study, MARS Medical Online Efficiency Run; 48X, 2015 Rates, Ad Page Exposures. Rank Based on an Efficiency Index.
Editorial Board Solid Tumors Bone Metastases Allan Lipton, MD Milton S. Hershey Medical Center Penn State University Hershey, PA
Prostate Cancer Michael A. Carducci, MD Johns Hopkins Kimmel Cancer Center Baltimore, MD
Andrew Seidman, MD Memorial Sloan-Kettering Cancer Center Weill Cornell Medical College New York, NY
Memorial Sloan-Kettering Cancer Center Weill Cornell Medical College New York, NY
Dana-Farber Cancer Institute Harvard Medical School Boston, MA
Edward Chu, MD
University of Alabama Birmingham, AL
Mayo Clinic Rochester, MN
Cathy Eng, MD
Dana-Farber Cancer Institute Harvard Medical School Boston, MA
Memorial Sloan-Kettering Cancer Center Weill Cornell Medical College New York, NY
Syed A. Abutalib, MD Cancer Treatment Centers of America Zion, Illinois
Community Oncology John W. Finnie, MD
Gastrointestinal Cancer and Sarcoma Ephraim Casper, MD Memorial Sloan-Kettering Cancer Center Weill Cornell Medical College New York, NY
Genitourinary Cancer
Mercy Medical Center St. Louis, MO
Michael J. Fisch, MD, MPH University of Texas MD Anderson Cancer Center Houston, TX
Ronald M. Bukowski, MD Taussig Cancer Center Cleveland Clinic Foundation Cleveland, OH
Steven Vogl, MD Medical Oncologist New York, NY
Gynecologic Cancer Maurie Markman, MD Cancer Treatment Centers of America Philadelphia, PA
Symptom Control and Palliative Care William S. Breitbart, MD Memorial Sloan-Kettering Cancer Center New York, NY
Lung and Head and Neck Cancers Edward S. Kim, MD Levine Cancer Institute Carolinas HealthCare Charlotte, NC
Lung Cancer, Emesis Richard J. Gralla, MD Hofstra North Shore-Long Island Jewish School of Medicine Monter Cancer Center North Shore University Hospital and Long Island Jewish Medical Center Lake Success, NY
University of Texas MD Anderson Cancer Center Houston, TX
Pharmacy Richard Stone, MD
Leonard Saltz, MD
City of Hope National Medical Center Duarte, CA
Michele Neskey, MMSc, PA-C
University of Pittsburgh Cancer Institute University of Pittsburgh Pittsburgh, PA
University of Texas MD Anderson Cancer Center Houston, TX
Oncology Nursing Betty Ferrell, RN, PhD
Shaji Kumar, MD
Gastrointestinal Cancer
University of California San Diego, CA
Jennifer R. Brown, MD, PhD
Harry Erba, MD, PhD Maura N. Dickler, MD
Beth Israel Medical Center New York, NY
Charles F. von Gunten, MD
Hematologic Malignancies Breast Cancer
Russell K. Portenoy, MD
Steven D. Passik, PhD Vanderbilt University Medical Center Nashville, TN
Cindy O’Bryant, PharmD University of Colorado Cancer Center Denver, CO
Sara S. Kim, PharmD The Mount Sinai Medical Center New York, NY
Bioethics Joseph P. DeMarco, PhD Cleveland State University Cleveland, OH
Paul J. Ford, PhD Cleveland Clinic Foundation Lerner College of Medicine of Case Western Reserve University Cleveland, OH
Policy and Management Mary Lou Bowers, MBA The Pritchard Group Rockville, MD
Matt Brow VP, Public Policy & Reimbursement Strategy McKesson Specialty Health The US Oncology Network Washington, DC
Infection Control Susan K. Seo, MD Memorial Sloan-Kettering Cancer Center New York, NY
Joseph V. Pergolizzi Jr., MD Johns Hopkins University School of Medicine Baltimore, MD
04-04-2016
2016 Editorial Calendar
January
July
Meeting Coverage: American Society of Hematology (ASH) Annual Meeting
Meeting Coverage: ASCO Annual Meeting
San Antonio Breast Cancer Symposium (SABCS)
Sarcomas Awareness Month
Cervical Cancer Awareness Month
February Meeting Coverage: Genitourinary Cancers Symposium CONFERENCE DISTRIBUTION: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), March 16-19, Boston
August Meeting Coverage: ASCO Annual Meeting Corporate Profiles*
September
Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, March 16-19, Atlanta
March Meeting Coverage: Gastrointestinal Cancers Symposium (GCS)
Free Ad Effectiveness Study Prostate Cancer Awareness Month Gynecologic Cancer Awareness Month Blood Cancer Awareness Month
National Colorectal Cancer Awareness Month Kidney Cancer Awareness Month
October
CONFERENCE DISTRIBUTION: American Association for Cancer Research (AACR), April 16-20, New Orleans
National Breast Cancer Awareness Month
April Meeting Coverage: The Association of Community Cancer Centers (ACCC) Annual Meeting Testicular Cancer Awareness Month CONFERENCE DISTRIBUTION: American Society of Colon and Rectal Surgeons (ASCRS), April 30-May 4, Los Angeles
May CONFERENCE DISTRIBUTION: American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, Chicago Skin Cancer Detection and Prevention Month National Melanoma/Brain Tumor Awareness Month
June
Liver Cancer Awareness Month CONFERENCE DISTRIBUTION: The Liver Meeting (American Association for the Study of Liver Diseases [AASLD]), November 11-15, Boston
November Meeting Coverage: European Society for Medical Oncology (ESMO) 2016 Congress Lung Cancer Awareness Month National Pancreatic Cancer Awareness Month CONFERENCE DISTRIBUTION: ASH Annual Meeting, Dec. 3-6, San Diego SABCS, December 6-10, San Antonio National Stomach Cancer Awareness Month
December Meeting Coverage: European Cancer Congress (ECC) ESMO
Meeting Coverage: The American Association for Cancer Research (AACR) Annual Meeting Cancer Immunotherapy Awareness Month
* Upon request 04-04-2016
2016 Print Advertising Rates
Black & White Rates
1x
Standard “A” page (Island page)
6x
12x
24x
36x
48x
72x
96x
120x
$1,840
$1,820
$1,800
$1,780
$1,760
$1,740
$1,720
$1,700
$1,680
King page (Tabloid page)
2,500
2,480
2,460
2,440
2,420
2,400
2,380
2,360
2,340
¾ King page
2,260
2,240
2,220
2,200
2,180
2,160
2,140
2,120
2,100
½ King page
1,800
1,780
1,760
1,740
1,720
1,700
1,680
1,660
1,640
¼ King page
1,400
1,380
1,360
1,340
1,320
1,300
1,280
1,260
1,240
Insert Rates
1x
6x
12x
24x
36x
48x
72x
96x
120x
2-page insert
$4,620
$4,600
$4,580
$4,560
$4,540
$4,520
$4,500
$4,480
$4,460
4-page insert
7,400
7,360
7,320
7,280
7,240
7,200
7,160
7,120
7,080
6-page insert
NA
10,900
10,850
10,800
10,750
10,700
10,650
10,600
10,550
8-page insert
NA
14,520
14,460
14,400
14,340
14,280
14,220
14,160
14,100
King insert rates: add $600 per page to above pricing
Color Charge: 2-Color—$600 3-Color—$900 4-Color—$1,150 5-Color—$2,050 Matched/Metallic—$900 Bleed: no charge
Premium Positions: 4th Cover—50% of earned B&W rate 2nd Cover, 3rd Cover, and other special positions—25% of earned B&W rate Front Cover Belly-Tip*: (quantity: 18,700) $14,950 Conference issues (May and November) $16,500 *This price is for a single sheet, 2-sided belly-tip with a maximum paper weight of 100# stock. Have another configuration such as a PI in a pocket, etc.? Provide a description/sample to your representative for more information.
Business Reply Card: $1,295 per 6" × 4" B&W card Commission: 15% agency discount allowed only if bill paid within 30 days
Total Circulation: 16,340
DEADLINES: Space Reservation: 1st of prior month Materials Due: 10th of prior month Issuance Date: 15th of each month Services to Readers and Advertisers: Editorial reprints available. Included in all syndicated readership services. Annual subscription: $220 ($300, international) Single issue: $25 ($35, international)
For the 6-month period ending July 2015
MD/DO Oncology����������������������������������������������������������������������������������������������������������������������������������������� 4,388 Hematology/Oncology�������������������������������������������������������������������������������������������������������������������� 8,143 Pediatric Hematology/Oncology���������������������������������������������������������������������������������������������������� 2,573 Gynecological Oncology������������������������������������������������������������������������������������������������������������������� 476 Surgical Oncology����������������������������������������������������������������������������������������������������������������������������� 427 Other specialties*������������������������������������������������������������������������������������������������������������������������������� 333 TOTAL � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 16,340 *
Includes all U.S. onc/hem-onc fellows, physicians (IMs, FPs, etc.), oncology nurse managers, directors, oncology nurse practitioners (NPs) and physician assistants (PAs).
04-04-2016
Print Production Specifications News
New Size!
Advertising Units
Width
Standard “A” page (Island)
Non-Bleed Sizes (Live Area: .25" all sides)
Trim Sizes Height
Width
Height
Bleed Sizes Width
Height
7.625"
10.5"
7.125"
10.25"
7.875"
10.75"
Standard “A” spread
15.25
10.5
14.75
10.25
15.5
10.75
King page (Tabloid)
10.5
14
10
13.5
10.75
14.25
21
14
20.5
13.5
21.25
14.25
7.625
14
7.125
13.5
7.875
14.25
¾ King page (horizontal)
10.5
10.5
10
10.25
10.75
10.75
½ King page (vertical)
5.25
14
4.75
13.5
5.5
14.25
½ King page (horizontal)
10.5
7
10
6.75
10.75
7.25
¼ King page (vertical)
5.25
7
4.75
6.75
5.5
7.25
7.625 10.5
4.875 3.5
7.125 10
4.375 3
7.875 10.75
5.125 3.75
6
4
5.5
3.5
6.25
4.25
10.375
4
10.125
3.75
10.625
4.25
King spread ¾ King page (vertical)
¼ King page (horizontal) Business Reply Card Front Cover Belly-Tip Publication Trim Size: 10.5 × 14
PRODUCTION REQUIREMENTS
SHIPPING INSTRUCTIONS
Page: 4 columns
Acceptable ad formats: Adobe Acrobat PDF files: Basic Distiller settings; no OPI; no ICC profiles; no trapping; embed all fonts; effective resolution minimum 300 dpi; include bleed; RGB files not accepted; convert composite fonts to outlines
Insertion Orders and Production Materials: McMahon Publishing Attn: Dan Radebaugh 545 West 45th St., 8th Fl. New York, NY 10036 Tel: (212) 957-5300 Fax: (815) 927-0494
[email protected]
Printing Process: Web offset Type of Binding: Saddle-stapled Inserts/Cover Tips: King and Journal size accepted. Allow 1⁄8-inch head trim for all inserts. On tabloid-size inserts, any excess will trim from face and foot. Smaller inserts, such as island size, should be delivered with clean trim except for the 1⁄8-inch head trim. For all inserts, to allow for tipping, no live text should appear within 5⁄8 inch of the gutter. Insert Quantity: 18,700
Acceptable software: Acrobat Distiller (PDF files) 4.x and 5.0 (recommended) FTP Information: FTP Site: ftp://66.147.219.4 Username: mcmahon Password: l3tm31n Ad Reproduction Guarantee: Accurate color reproduction cannot be guaranteed without a ripped proof. RIPPED, RULED PROOFS MUST BE SUPPLIED FOR ALL ADS
Inserts to: Cenveo Publisher Services Attn: John Ford 2901 Byrdhill Road Insert Storage Richmond, VA 23228 Tel: (804) 515-5119
Receivables: McMahon Publishing 545 W. 45th St., 8th Fl. New York, NY 10036 Attn: Mariella Sindoni Tel: (212) 957-5300 x909 Fax: (646) 274-4112
[email protected]
DEADLINES: Space Reservation: First of prior month Materials Due: 10th of prior month Issuance Date: 15th of each month
Staff and Contact Information Advertising, Editorial, Finance & Production Offices 545 W. 45th St., 8th Fl. New York, NY 10036 Tel: (212) 957-5300 Fax: (815) 927-0494 Corporate Office West Redding, CT Publisher Raymond E. McMahon Director, Medical Education Joseph Malichio, ext. 286
[email protected]
McMahon Publishing is a 44-year-old, family-owned medical publisher of clinical newspapers and specialty periodicals, and creates compelling medical education programs and custom publications.
SALES CONTACTS Julianna Dawson, ext. 271
[email protected]
Managing Editor Sarah Tilyou
[email protected]
Michael Enright, ext. 272
[email protected]
Art Director Frank Tagarello/MAX Graphics Director of Production & Technical Operations Dan Radebaugh, ext. 231
[email protected] Circulation Manager Brandy Wilson, ext. 362
[email protected]
CUSTOM MEDIA
04-04-2016
Previou paymen
Vogl, NY...: “Screen, Baby, Screen”...........................21
New Product Program
New pa Average
The Tumor Board: A large mass at the small bowel mesentery ............................... 24
Percent
Commu in a surv to chan patients
Maurie Markman, MD: Does ‘X’ cause cancer?......................................26
FORMO M FOR
By the Number SequesD Clinical
“Bubblehead,” a creation of clustered pancreatic adenocarcinoma cells. For more info, see page 8.
3-Month New Product/Service Introduction Program Clinical Conundrums........................... .27
EDUCATIONAL REVIEW
The single biggest question facing community oncolo
With a 3-month advertising commitment, you can choose 3 ofYou the following: Will Merge or Guide to Colorectal Cancer Therapeutic Regimens 2013 Pocket Guide.........insert after page 8
NEW PRODUCT
❶
Front Cover New Product Announcement & Press Release Value $2,500 Receive a front cover new product announcement that directs the reader to a Press Release inside (color photo or Cetuximab Gets New Indication In Head and Neck Cancer logo and 50-75 words of text).
Cetuximab (Erbitux, BMS) gets.new.head.and.neck. cancer.indication.
T
❷ ❹
he FDA has approved cetuximab (Erbitux, Bristol-Myers Squibb) in combination with platinum-based chemotherapy with 5-fluorouracil, for the first-line treatment of recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN). This is the first treatment regimen approved in 30 years with extended overall survival in patients with recurrent locoregional or metastatic SCCHN, according to the drugmaker.
For more information, go to http://www.bms.com/
Ad on Website or in Opt-In e-Newsletter Value $2,500 Medium Rectangle (300 X 250) for a month on our website, or in our e-newsletter, subject to availability.
See page 6.
Value $2,000 Market research from 5 YES/NO multiple-choice questions to our database of oncologists and hematologist/ oncologists (minimum 100 responses guaranteed).
see PRESSURE, page 1
For more information, go to http://www.bms.com/
Cover Tip
YOUR COVER TIP HERE
Product Information
PRODUCT INFO
Value $2,000 500 words wrapped around an A-size ad.
YOUR AD HERE
For more information, or to reserve advertising space, please contact: Julianna Dawson •
[email protected] • (212) 957-5300 x271 Michael Enright •
[email protected] • (212) 957-5300 x272 All materials are needed one week prior to closing date.
3. Uncertainty c impact of he
4. An aging onc
Scott Okuno, MD
he FDA has approved cetuximab (Erbitux, Bristol-Myers Squibb) in combination with platinum-based chemotherapy with 5-fluorouracil, for the first-line treatment of recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (SCCHN). This is the first treatment regimen approved in 30 years with extended overall survival in patients with recurrent locoregional or metastatic SCCHN, according to the drugmaker.
❺
2. Uncertainty r Sustainable G for Medicare
Percutaneous cryoablation eases metastatic bone pain ............................. 14
T
❸
1. The Medicare reducing me rates to the A
Expert Insights From M
Cetuximab Gets New Indication In Head and Neck Cancer
Value $2,000 Discount of $2,000 on a cover tip on Clinical Oncology News, subject to availability.
Four Trend Practice Co
R E V I E WS & CO M M E N T
New ProduCt
YOUR AD HERE
Informative Market Research
T
Press Release jumps to inside
New ProduCt
Won’t
here are two kinds of community oncology practices today, says Patrick Cobb, MD, of St. Vincent Frontier Cancer Center in Billings, Mont.: those that have aligned with a hospital or health system, and those that are thinkFront Cover Announcement ing about it. As of December 2012, Dr. Cobb’s practice is one of the former. “That’s when we officially signed a contract with St. Vincent’s Healthcare to transition us from a private practice clinic to a hospital-based clinic,” Dr. Cobb says. “We couldn’t see any other way that we’d be able to continue to practice given the current economic environment.” Over the last four-and-a-half years, according to an April 2012 Community Oncology Practice Impact report from the Community Oncology Alliance (COA), 241 community oncology clinics have closed altogether; 132 either have merged with or have been acquired by another practice or a corporate entity (like McKesson’s 2010 purchase of US Oncology); and 392 practices either have
William Won